Moderna, Inc. 4

Moderna President Stephen Hoge had RSUs vest into common stock on August 27–28, 2026, with a portion of the resulting shares withheld to cover taxes.

On August 27 and 28, 2026, Moderna President Stephen Hoge reported routine vesting and settlement of restricted stock units (RSUs) into common stock, along with related share withholding for taxes. On August 27, an RSU tranche for 1,437 shares converted into common stock, increasing his directly held common stock, followed by the withholding of 695 shares at $149.66 per share to satisfy tax obligations. On August 28, a second RSU tranche of 611 shares vested into common stock, with 296 shares withheld at $142.77 per share for taxes. These Form 4 entries reflect non‑open‑market, compensation-related transactions (coded “M” for conversion and “F” for tax withholding) rather than discretionary purchases or sales, and Hoge’s direct and indirect holdings (including positions via Valhalla, LLC and a family trust) remain substantial following the transactions.

Filing Facts

CIK

1682852

Ticker

MRNA

Form

4

Source Type

fda

Accession

0001682852-26-000161

Alert Tier

7